Clinical trial

Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening

NCT06021652

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention MindCotine Virtual reality Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-09-01

PhaseNA

Conditions

Tobacco Use Cessationunresolved

Interventions

MindCotine Virtual realityDEVICE

Sponsors & collaborators

Cedars-Sinai Medical Centerlead sponsor

MindCotinecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06021652 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.